Paul Tudor Jones's KURA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 43,520 shares of Kura Oncology, Inc. (KURA) worth $353,818, representing 0.00% of the portfolio. First purchased in 2019-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in KURA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 44,020 shares. Largest reduction occurred in Q1 2025, reducing 38,805 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Kura Oncology (KURA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kura Oncology (KURA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -500 | Reduce 1.14% | 43,520 | $8.13 |
| Q4 2025 | +44,020 | New Buy | 44,020 | $10.39 |
| Q1 2025 | -38,805 | Sold Out | 0 | $0.00 |
| Q4 2024 | +38,805 | New Buy | 38,805 | $8.71 |
| Q3 2023 | -34,839 | Sold Out | 0 | $0.00 |
| Q2 2023 | +34,839 | New Buy | 34,839 | $10.58 |
| Q1 2022 | -36,843 | Sold Out | 0 | $0.00 |
| Q4 2021 | +36,843 | New Buy | 36,843 | $14.01 |
| Q1 2021 | -12,316 | Sold Out | 0 | $0.00 |
| Q4 2020 | +12,316 | New Buy | 12,316 | $32.64 |
| Q3 2019 | -17,901 | Sold Out | 0 | $0.00 |
| Q2 2019 | +17,901 | New Buy | 17,901 | $19.66 |
Paul Tudor Jones's Kura Oncology Investment FAQs
Paul Tudor Jones first purchased Kura Oncology, Inc. (KURA) in Q2 2019, acquiring 17,901 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Kura Oncology, Inc. (KURA) for 12 quarters since Q2 2019.
Paul Tudor Jones's largest addition to Kura Oncology, Inc. (KURA) was in Q4 2025, adding 44,020 shares worth $457,368.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 43,520 shares of Kura Oncology, Inc. (KURA), valued at approximately $353,818.
As of the Q1 2026 filing, Kura Oncology, Inc. (KURA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Kura Oncology, Inc. (KURA) was 44,020 shares, as reported at the end of Q4 2025.